Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis
NCT04593251
Celiac Disease, Digestive System Diseases
Brussels, Belgium
View Trial DetailsNCT Number: NCT02190513
Celiac disease (CD) and eosinophilic esophagitis (EE) are distinct diseases of the gastrointestinal tract with specific clinico-pathological characteristics. In recent years, in the literature, several children who underwent upper gastrointestinal endoscopy for suspected CD, which was confirmed histologically, were also found to have coexistent EE. There are reports of coexistent CD and EE. We would like to see the prevalence of EE in children with CD and the prevalence of CD in children with EE in our population, and to do so would like to review medical records. Our objectives are to determine if children with celiac disease have a high prevalence of eosinophilic esophagitis.and to determine if children with eosinophilic esophagitis have increased risk of developing celiac disease.
Looking for future studies?
Notify Me2 year–21 year
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Retrospective chart review study, no contact made with patients, so no patient time is required, expected average of 2 years
St. John Health System, Michigan
Other
Prevalence of Eosinophilic Esophagitis in Children With Celiac Disease and Prevalence of Celiac Disease in Children With Eosinophilic Esophagitis in a Tertiary Community Hospital
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04593251
Celiac Disease, Digestive System Diseases
Brussels, Belgium
View Trial DetailsNCT02072590
Celiac Disease, Digestive System Diseases
Tampere, Finland
View Trial DetailsNCT07063823
Celiac Disease, Digestive System Diseases
Stanford, California, United States
View Trial DetailsNCT07177287
Adults With Celiac Disease, Celiac Disease
Ankara, Turkey (Türkiye)
View Trial Details